September 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 1,127.65 million in 2026, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
September 2026
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 18.06 billion in 2026, with a CAGR of 26.62%.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
July 2026
The cell and gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The US cell and gene therapy market generated USD 4.74 billion in 2026, with prominent US cell and gene therapy market companies including Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., CORESTEM Inc.
July 2026
The cell and gene therapy patient access and reimbursement market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 10.33 billion in 2026, with a CAGR of 27.92%.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
June 2026
The global cell therapy manufacturing market size was valued at USD 5.55 billion in 2025 and is projected to hit around USD 21.02 billion by 2035 with a CAGR of 14.24%.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
April 2026
The global cell and gene therapy market size was calculated at USD 8.94 billion in 2025 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
December 2025
The global cell and gene supply chain services market size is expected to hit over USD 4.65 billion by 2035 from USD 1.75 billion in 2025, with CAGR of 10.27%.
December 2025
The global automated and closed cell therapy processing system market size is expected to hit around USD 14.46 billion by 2035 with a CAGR of 22.76%.
September 2026
The global allogeneic cell therapy devices market size is projected to hit around USD 4,565.79 million by 2035 from USD 511.30 million in 2025 with a CAGR of 24.48%.
September 2026
The global personalized cell therapy market size was evaluated at USD 46.06 billion in 2026 and is predicted to reach around USD 235.65 billion by 2034, with a CAGR of 22.81%.
July 2025
The global regenerated cellulose market size was calculated at USD 24.91 billion in 2026 and is projected to hit around USD 50.37 billion by 2034 with a CAGR of 9.20%.
September 2026
The generative AI in manufacturing market size reached USD 889.32 million in 2026, with leading generative AI in manufacturing market companies including SAP SE, IBM, Microsoft Corporation.
September 2026
The global generic pharmaceuticals contract manufacturing market size is projected to hit around USD 135.36 billion by 2034 from USD 85.96 billion in 2026 with a CAGR of 5.84%.
September 2026
The global stem cell manufacturing market size reached USD 17.57 billion in 2026 and is projected to surpass around USD 45.38 billion by 2035, with a solid CAGR of 11.13%.
August 2026
The autologous stem cell and non-stem cell based therapies market size stood at USD 10.75 billion in 2026, with major autologous stem cell and non-stem cell based therapies market companies including Vericel Corporation, Holostem Terapie Avanzate, Anterogen Co. Ltd., BrainStorm Cell Therapeutics.
July 2026
The single dose gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
September 2026
The healthcare contract development and manufacturing organization market size reached USD 291.03 billion in 2026, with leading healthcare contract development and manufacturing organization market companies including onza Group Ltd., Covance Inc., Flex.
September 2026
The electronic contract manufacturing and design services market size is estimated to hit around USD 1,544.97 billion by 2034 from USD 735.59 billion in 2026 with a CAGR of 9.72%.
September 2026
The pharmaceutical contract manufacturing and research services market size is estimated to hit around USD 525.32 billion by 2035, increasing from USD 282.99 billion in 2026, with a CAGR of 7.11%.
September 2026
The global dental implants and prosthetics contract manufacturing market size is estimated to hit around USD 3.41 billion by 2035 increasing from USD 1.68 billion in 2026, with a CAGR of 8.20%.
September 2026
The global contract development manufacturing organization outsourcing market size is projected to hit around USD 824.16 billion by 2034 increasing from USD 234.71 billion in 2026, with a CAGR of 17.00%.
September 2026
The global generative AI in the media and entertainment market size was evaluated at USD 2.8 billion in 2026 and is predicted to hit around USD 21.2 billion by 2035, growing at a CAGR of 25.2%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com